Samlyn Capital »

Axsome Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $60M 246k 244.77

More positions owned by Samlyn Capital

Lpl Financial Holdings (LPLA)
Primo Brands Corporation Class A Com Shs (PRMB)
First Solar (FSLR)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Blackrock (BLK)
Liberty Media Corp Del Com Lbty One S C (FWONK)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Morgan Stanley Com New (MS)
VSE Corporation (VSEC)
Bank of America Corporation (BAC)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Willscot Hldgs Corp Com Cl A (WSC)
Kaspi Kz Jsc Sponsored Ads (KSPI)
BorgWarner (BWA)

View all positions for Samlyn Capital

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Susquehanna International
Jane Street
Deep Track Capital
Two Sigma Investments
Franklin Resources
Wellington Management Company
D. E. Shaw & Co

View all funds holding Axsome Therapeutics